Our study demonstrated that CEA, EpCAM, and c-MET are abundantly expressed in rectal cancer tumors, with nCRT exerting minimal impact on their expression in both tumor and adjacent normal tissues. This evidence concerns the gene CEACAM5 and neoplasm.